Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Aug;32(3):273-80.
doi: 10.1016/j.soncn.2016.05.007. Epub 2016 Jul 29.

Cancer Prevention: HPV Vaccination

Review

Cancer Prevention: HPV Vaccination

Tami L Thomas. Semin Oncol Nurs. 2016 Aug.

Abstract

Objectives: To provide an overview of human papillomavirus (HPV) vaccination as cancer prevention with current strategies that nurses can use to help patients and parents overcome barriers to HPV vaccination.

Data sources: Peer-reviewed literature, presentation abstracts, and current immunization recommendations from the Advisory Council on Immunization Practice.

Conclusion: Nurses can help prevent cancer by encouraging HPV vaccination during routine immunization and make HPV vaccination normal and routine.

Implications for nursing practice: A vaccine to reduce/eliminate HPV-related cancers enables nurses' at all educational levels to advocate for cancer prevention through initiation and completion of the HPV vaccine series.

Keywords: HPV vaccination; cancer; human papillomavirus; nursing practice; oncology nursing; prevention.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Noninfectious HPV VLP (vaccine) versus Infectious HPV Virus
Credited to Dr. Timothy Baker with permission. Timothy S. Baker, Professor Departments of Chemistry & Biochemistry and Molecular Biology University of California, San Diego HPV – Human Papillomavirus HPV VLP – HPV Virus Like Particles – resembles HPV but is non-infectious Viral DNA – deoxyribonucleic acid: a main component of chromosomes and the material that transfers genetic characteristics, in this case the DNA of HPV L2, L2 protein – protein expressed by HPV subtypes 16 and 18 that are linked to cancer cell production Capsid Proteins - outer cap layer of the HPV also known as viral structural proteins which can result in the self-assembly of VPLs or Virus Like Particles
Figure 2
Figure 2
Suggested progressive steps to overcoming barriers to HPV vaccination series completion

References

    1. Harper DM, Franco EL, Wheeler C, et al. HPV Vaccine Study Group. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: Follow-up from a randomized controlled trial. Lancet. 2006;367(9518):1247–1255. - PubMed
    1. Georgia Center for Cancer Statistics Georgia Department of Human Resources. [Accessed January 25, 2015];2008 http://web1.sph.emory.edu/GCCS/cms/index.html.
    1. Parkin DM, Bray F. The burden of HPV-related cancers. Vaccine. 2006;24(Suppl 3):S3/11–S3/25. - PubMed
    1. Watson M, Saraiya M, Benard V, et al. Burden of cervical cancer in the United States, 1998–2003. Cancer. 2008;113(10 Suppl):2855–2864. - PubMed
    1. Kroger AT, Atkinson WL, Marcuse EK, Pickering LK. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep. 2006;55(RR-15):1–48. - PubMed

Substances